News

The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with ...
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...
Police across Europe have dismantled a dark web drug marketplace known as 'Archetyp Market', the pan-European Europol police ...
The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...
The US Food and Drug Administration announced a new national priority voucher plan that aims to cut drug review times to one ...
The company said that it will instead use natural colors for products including kool aid, crystal light and more.
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...
The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...
The FDA announced a new fast-track approval program for domestic drug developers for projects that are national priorities.
Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...